Document Detail


Carotid artery intima-media thickness and lipid profile in adults with growth hormone deficiency after long-term growth hormone replacement.
MedLine Citation:
PMID:  15736109     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To investigate the effects of growth hormone (GH) replacement on carotid artery intima-media thickness (IMT) and lipid profile, 29 adults with GH deficiency (GHD), mean age 42.5 +/- 10.1 years, were studied and compared with 29 control subjects matched for sex, age, body mass index, and smoking habits. Lipid profile (total cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein cholesterol, apolipoproteins A and B, and lipoprotein), serum insulin-like growth factor 1 (IGF-1) levels, and ultrasonography of the carotid arteries were performed at baseline and at 6, 12, and 24 months during GH therapy on maintenance dose. At baseline, when compared with the control group, patients presented increased carotid artery IMT (P < .05) and triglyceride levels (P < .001) and lower HDL concentrations (P < .01). In a linear regression analysis, age and known mean duration of GHD were correlated with carotid artery IMT. After 24 months of GH replacement, a reduction in the mean of carotid artery IMT was observed (P < .01). The apolipoprotein B levels decreased significantly after the first 3 months of GH treatment (P < .001) and remained stable thereafter. Women also presented an increase in HDL cholesterol levels (P < .01). No differences were observed in the other lipids measured. Carotid artery IMT at baseline was inversely correlated with the change in carotid artery IMT (Delta = 24 months - baseline), r = 0.63, P < .001. In conclusion, 24 months of GH replacement therapy promoted favorable effects on carotid artery IMT and lipid profile in patients with GHD. Long-term follow-up studies are required to show whether these beneficial effects will result in reduction of morbidity and mortality from vascular disease.
Authors:
Débora Vieira Soares; Luciana Diniz Carneiro Spina; Rosane Resende de Lima Oliveira Brasil; Eliane Maria Carvalho da Silva; Priscila Marise Lobo; Elizabeth Salles; Claúdia Medina Coeli; Flávia Lúcia Conceição; Mario Vaisman
Related Documents :
14642409 - Arterial stiffness is rapidly induced by raising the plasma homocysteine concentration ...
11058709 - Apolipoprotein e polymorphism and carotid artery intima-media thickness in a random sam...
16196179 - Non-invasive assessment of arterial stiffness by pulse-wave velocity correlates with en...
10841519 - Angiotensin ii promotes atherosclerotic lesions and aneurysms in apolipoprotein e-defic...
17384039 - Common carotid artery intima-media thickness determinants in a population study.
10677919 - Significantly higher levels of oxidized ldl autoantibody in coronary artery disease pat...
10102529 - Atypical pulmonary artery sling with diffuse-type pulmonary arteriovenous fistula.
25467919 - Stenting for curved lesions using a novel curved balloon: preliminary experimental study.
17880959 - Uterine artery pseudoaneurysm manifesting delayed postabortal bleeding.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Metabolism: clinical and experimental     Volume:  54     ISSN:  0026-0495     ISO Abbreviation:  Metab. Clin. Exp.     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-02-28     Completed Date:  2005-05-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375267     Medline TA:  Metabolism     Country:  United States    
Other Details:
Languages:  eng     Pagination:  321-9     Citation Subset:  IM    
Affiliation:
Service of Endocrinology, Clementino Fraga Filho University Hospital, Federal Universtity of Rio de Janeiro, CEP 21941590, Brazil. wellbs@terra.com.br
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Apolipoproteins B / blood
Carotid Arteries / pathology*,  ultrasonography
Cholesterol, HDL / blood
Female
Hormone Replacement Therapy
Human Growth Hormone / deficiency*,  therapeutic use*
Humans
Linear Models
Lipids / blood*
Male
Middle Aged
Prospective Studies
Triglycerides / blood
Tunica Intima / pathology*
Tunica Media / pathology*
Chemical
Reg. No./Substance:
0/Apolipoproteins B; 0/Cholesterol, HDL; 0/Lipids; 0/Triglycerides; 12629-01-5/Human Growth Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with...
Next Document:  Altered relationship between body fat and plasma adiponectin in end-stage renal disease.